KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy
Clinical trial NCT05427383 · RECRUITING
Trial details
- NCT number
- NCT05427383
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-07
- Primary completion
- 2025-11-01
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.